HENRY SCHEIN, INC. Temporary Equity, Elimination as Part of Reorganization
HENRY SCHEIN, INC. (HSIC) reported Temporary Equity, Elimination as Part of Reorganization of $273.00 million for the 12-month period ending 2024-12-28, per its 10-K filed 2025-02-25.
Financial Statements › Shareholders' Equity
us-gaap:TemporaryEquityEliminationAsPartofReorganization · last filed 2025-02-25
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for the quarter ending 2022-12-31 was $5.00M, a 48.50% decline year-over-year.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for the quarter ending 2022-09-24 was $15.00M, a 69.49% decline year-over-year.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for the quarter ending 2022-06-25 was $8.00M, a 607.96% increase year-over-year.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for the quarter ending 2022-03-26 was $3.00M.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for fiscal 2024 was $273.00M, a 1336.84% increase from fiscal 2023.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for fiscal 2023 was $19.00M, a 38.71% decline from fiscal 2022.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for fiscal 2022 was $31.00M, a 48.33% decline from fiscal 2021.
- HENRY SCHEIN, INC. temporary equity, elimination as part of reorganization for fiscal 2021 was $60.00M, a 252.94% increase from fiscal 2020.
| Period end | Temporary Equity, Elimination as Part of Reorganization 3 month | Temporary Equity, Elimination as Part of Reorganization 6 month | Temporary Equity, Elimination as Part of Reorganization 9 month | Temporary Equity, Elimination as Part of Reorganization 12 month | Temporary Equity, Elimination as Part of Reorganization 12 month as first filed |
|---|---|---|---|---|---|
| 2024-12-28 | $273.00M 10-K · filed 2025-02-25 | ||||
| 2023-12-30 | $19.00M 10-K · filed 2025-02-25 | ||||
| 2022-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $20.00M derived: sum of 2 quarters · filed 2025-02-25 | $28.00M derived: sum of 3 quarters · filed 2025-02-25 | $31.00M 10-K · filed 2025-02-25 | |
| 2022-09-24 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $23.00M derived: sum of 2 quarters · filed 2022-11-01 | $26.00M 10-Q · filed 2022-11-01 | $35.71M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-25 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $11.00M 10-Q · filed 2022-08-02 | $20.71M derived: sum of 3 quarters · filed 2024-02-28 | $69.87M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-26 | $3.00M 10-Q · filed 2022-05-03 | $12.71M derived: sum of 2 quarters · filed 2024-02-28 | $61.87M derived: sum of 3 quarters · filed 2024-02-28 | $63.00M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-25 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $58.87M derived: sum of 2 quarters · filed 2024-02-28 | $60.00M derived: sum of 3 quarters · filed 2024-02-28 | $60.00M 10-K · filed 2024-02-28 | $60.24M 10-K · filed 2022-02-15 |
| 2021-09-25 | $49.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $50.29M derived: sum of 2 quarters · filed 2021-11-02 | $50.29M 10-Q · filed 2021-11-02 | $54.66M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-06-26 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $1.13M 10-Q · filed 2021-08-03 | $5.49M derived: sum of 3 quarters · filed 2023-02-21 | $5.49M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2021-03-27 | $0.00 10-Q · filed 2021-05-04 | $4.36M derived: sum of 2 quarters · filed 2023-02-21 | $4.36M derived: sum of 3 quarters · filed 2023-02-21 | $4.36M derived: sum of 4 quarters · filed 2023-02-21 | |
| 2020-12-26 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21 | $4.36M derived: sum of 2 quarters · filed 2023-02-21 | $4.36M derived: sum of 3 quarters · filed 2023-02-21 | $17.00M 10-K · filed 2023-02-21 | $17.24M 10-K · filed 2021-02-17 |
| 2020-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $0.00 derived: sum of 2 quarters · filed 2020-11-02 | $12.64M 10-Q · filed 2020-11-02 | ||
| 2020-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $12.64M 10-Q · filed 2020-08-04 | |||
| 2020-03-28 | $12.64M 10-Q · filed 2020-05-05 | ||||
| 2019-12-28 | $2.27M 10-K · filed 2022-02-15 | ||||
| 2018-12-29 | $287.77M 10-K · filed 2021-02-17 | ||||
| 2017-12-30 | $22.29M 10-K · filed 2020-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/ (ACH) | United States | $0.057B | -0.87 |